Search results
Results From The WOW.Com Content Network
Repros Therapeutics Inc. was a US-based development stage biopharmaceutical company headquartered in The Woodlands, Texas. Founded in 1987 as Zonagen, it focused on the development of oral small molecule drugs to address major unmet medical needs in male and female health. Joseph S. Podolski was the CEO of this company. [1]
Assertio Therapeutics, Inc. (formerly Depomed, Inc.) is an American specialty pharmaceutical company. [3] It mainly markets products for treatment in neurology , pain and diseases of the central nervous system . [ 4 ]
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C.
Mirati Therapeutics works largely in KRAS-mutation inhibition, and developing treatments for tumors that contain it. [3] The inhibition to the mutation has shown to shrink the size of its tumors. [4] The company is based in San Diego, California. [5] The company’s name comes from the Italian word for “targeted” (Mirati).
After having been a director since December 2019, Duggan was appointed as CEO of Summit Therapeutics, a clinical-stage drug development company focused on new mechanism antibiotics, in spring 2020. [40] He is the company's leading shareholder and its CEO. [40] Summit is focused on developing ridinilazole, a potential new treatment for C ...
Spectrum Pharmaceuticals, Inc. is an American biopharmaceutical company located in Boston, MA.It develops and markets drugs for treatments in hematology and oncology.. After a deal valued at $248 million was announced in April 2023, [1] [2] Assertio Holdings announced that it had completed its acquisition of the Massachusetts-based company on July 31.
Osiris Therapeutics, Inc. was an American company founded in March 1993 following the identification of mesenchymal stem cells (MSCs) by Dr. Arnold Caplan and colleagues at Case Western Reserve University in Cleveland, Ohio. [1]
Cerevel Therapeutics Holdings, Inc. was an American biotechnology and pharmaceuticals company based in Cambridge, Massachusetts, focused on the development of novel therapies for mental and neurological illnesses.